New ACR guidelines for juvenile idiopathic arthritis favor DMARDs over NSAIDs

Early and aggressive intervention is recommended for children with juvenile idiopathic arthritis, according to new 2026 guidelines from the American College of Rheumatology.“If a child has damage from untreated or undertreated arthritis, that will follow them forever,” Karen Onel, MD, chief of the division of pediatric rheumatology at the Hospital for Special Surgery, and professor of